Publications by authors named "Elizabeth Mittendorf"

Claim this Profile
C
Cell populations in human breast cancers are molecularly and biologically distinct with age.
Adrienne Parsons, Esther Sauras Colón, Meghana Manjunath, Hanyun Zhang, Julia Chen, Elizabeth A Mittendorf

Nat Aging· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast Cancer Presentation and Treatment Patterns in Sexual and Gender Minorities.
Gabi Barmettler, Saskia Leonard, Andreas Giannakou, Ko Un Park, Claire E Smith, Elizabeth A Mittendorf

Ann Surg Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Breast Cancer-Related Lymphedema on Cancer Care Costs: Longitudinal and Age-Based Analyses.
Anne Marie Raymakers, Tari A King, Elizabeth A Mittendorf, Tanujit Dey, Mahima Jain

Ann Surg Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing racial disparities in disease outcomes of patients with high-risk, triple-negative breast cancer and residual disease after neoadjuvant therapy: a post-hoc analysis of the ECOG-ACRIN 1131 clinical trial.
Kate Lloyd, Lisa A Newman, Charity Glass, Esther R Ogayo, Erica L Mayer, Elizabeth A Mittendorf

Breast Cancer Res Treat· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgeon Perspectives on Axillary Management Following Neoadjuvant Endocrine Therapy: Results from a Qualitative Substudy of the PELOPS Trial.
Anna Weiss, Anna Revette, Brett Nava-Coulter, Elizabeth A Mittendorf, Otto Metzger Filho

Ann Surg Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axillary Management and Outcomes After Neoadjuvant Endocrine Therapy in the Randomized PELOPS Trial.
Anna Weiss, Qingchun Jin, Nabihah Tayob, Eileen Wrabel, Michelle DeMeo, Elizabeth A Mittendorf

Ann Surg Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, safety, and predictive biomarkers of neoadjuvant nab-paclitaxel and pembrolizumab in hormone receptor-positive breast cancer: A randomized pilot trial.
Adrienne G Waks, Jingxin Fu, Xiangying Chu, Busem Binboga Kurt, Tianyu Li, Elizabeth A Mittendorf

Nat Commun· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular reprogramming during anti-PD-1 and chemotherapy treatment in early-stage primary hormone receptor-positive breast cancer.
Jingxin Fu, Adrienne G Waks, Erica Pimenta, Breanna Titchen, Kevin Bi, Elizabeth A Mittendorf

Nat Commun· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plain language summary of publication: Comparing nivolumab and neoadjuvant chemotherapy with placebo and neoadjuvant chemotherapy in participants with newly diagnosed estrogen receptor-positive breast cancer in the CheckMate 7FL clinical trial.
Sherene Loi, Roberto Salgado, Giuseppe Curigliano, Roberto Iván Romero Díaz, Suzette Delaloge, Elizabeth A Mittendorf

Future Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preliminary Efficacy/Feasibility Study of a Breast Cancer-Related Lymphedema Prospective Screening and Early Intervention Program at the Dana-Farber Brigham Cancer Center.
Sara P Myers, Jacob M Jasper, Tessa Higgins, Angela Serig, Amanda C Faust, Elizabeth A Mittendorf

J Clin Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of tumor-infiltrating lymphocyte subtypes with clinical characteristics and prognosis in young women with hormone receptor-positive breast cancer.
Megan E Tesch, Yue Zheng, Yaileen D Guzman-Arocho, Laura C Collins, Yu Jing J Heng, Elizabeth A Mittendorf

Clin Cancer Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frailty and Postoperative Complications in Older Adults With Nonmetastatic Breast Cancer.
Eliza H Lorentzen, Yu-Jen Chen, Claire Morton, Tari A King, Elizabeth A Mittendorf

JAMA Netw Open· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
APOE+ Tumor-Associated Macrophages and CD4-DOCK4 T Cells Reveal Distinct Microenvironmental Features in HER2-Low and HER2-0 Hormone Receptor-Positive Breast Cancer.
Carlos Wagner S Wanderley, Daniel E Michaud, Kenichi Shimada, Adam Nelson, Jingxin Fu, Elizabeth A Mittendorf

bioRxiv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of age and treatment-related adverse events on financial toxicity among patients with breast cancer: a systematic review.
Sara P Myers, Claire R Morton, Paul A Bain, Samilia Obeng-Gyasi, Electra D Paskett, Elizabeth A Mittendorf

J Cancer Surviv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Downstream Effects of Omission of Axillary Surgery in Older Adults with Early-Stage HR+/HER2- Breast Cancer.
Eliza H Lorentzen, Kenny Nguyen, Yu-Jen Chen, Tari A King, Elizabeth A Mittendorf

Ann Surg Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omission of multimodal therapy in older adults with high-risk breast cancer.
Eliza H Lorentzen, Yu-Jen Chen, Annabelle L Jones, Olga Kantor, Tari A King, Elizabeth A Mittendorf

Breast Cancer Res Treat· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of ipsilateral breast tumor recurrence after prior breast conservation therapy.
Jacob M Jasper, Halley Vora, Olga Kantor, Monica McGrath, Jennifer R Bellon, Elizabeth A Mittendorf

Breast Cancer Res Treat· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peri-operative atezolizumab in early-stage triple-negative breast cancer: final results and ctDNA analyses from the randomized phase 3 IMpassion031 trial.
Elizabeth A Mittendorf, Zoe June Assaf, Nadia Harbeck, Hong Zhang, Shigehira Saji

Nat Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic single-cell systemic immune responses in immunotherapy-treated early-stage HR+ breast cancer patients.
Xiaopeng Sun, Margaret L Axelrod, Adrienne G Waks, Jingxin Fu, Molly DiLullo, Elizabeth A Mittendorf

NPJ Breast Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Postneoadjuvant Prognostic Breast Cancer Staging System.
David J Winchester, Lavisha Singh, Stephen B Edge, Kimberly H Allison, William E Barlow, Elizabeth A Mittendorf

J Clin Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: a phase II trial (NIMBUS).
Romualdo Barroso-Sousa, Jorge Gomez Tejeda Zanudo, Tianyu Li, Sangeetha M Reddy, Leisha A Emens, Elizabeth A Mittendorf

Nat Commun· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of breast radiotherapy on the tumor genome and immune ecosystem.
Aislyn Schalck, Tuan Tran, Jianzhuo Li, Emi Sei, Shanshan Bai, Elizabeth A Mittendorf

Cell Rep· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Study of Abemaciclib for Patients with Retinoblastoma-Positive, Metastatic Triple-Negative Breast Cancer.
Shom Goel, Bojana Jovanović, Xiangying Chu, Melissa Hughes, Timothy K Erick, Elizabeth Mittendorf

Clin Cancer Res· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent Advances in Immune Checkpoint Inhibitors for Triple-Negative Breast Cancer.
Chiara Corti, Beyza Koca, Tasnim Rahman, Elizabeth A Mittendorf, Sara M Tolaney

Immunotargets Ther· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of ribociclib (CDK4/6 inhibitor) with spartalizumab (PD-1 inhibitor) with and without fulvestrant in metastatic hormone receptor-positive breast cancer or advanced ovarian cancer.
Ana C Garrido-Castro, Noah Graham, Lestat R Ali, Christina Herold, Jennifer Desrosiers, Elizabeth A Mittendorf

J Immunother Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis